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Abstract
A person’s sex can be considered across various levels. To illustrate, genes,
hormones, and genitalia can all be considered physical markers of a person’s
sex. In addition to physical markers, behaviors such as gender role, gender
identity and sexual orientation can be perceived as stereotypically male or
female. The purpose of this review is to summarize current knowledge of sex-
ual differentiation which emphasizes genetic and hormonal mechanisms that
result in male and female development of gonads and genitalia. Finally, con-
sideration is given to associations between genetic sex, gonadal sex, and hor-
monal sex with gender.
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Introduction
Stedman’s Medical Dictionary defines sex as the bio-
logical qualities that distinguish between male and fe-
male. These qualities are expressed by an individual’s
chromosomal, gonadal, morphological (internal and ex-
ternal) and hormonal characteristics. Sex is also defined
as the physiological and psychological processes within an
individual which prompt behavior related to procreation
and/or erotic pleasure. Gender is defined as the sex of
assignment. Gender can be further partitioned into gen-
der role and gender identity, which refer to the sex of a
person assigned by society and the sex of a person
assigned by himself respectively [1]. An attempt is made
to describe associations between biological qualities of sex
and gender in humans, and also to bring attention to the
need for further investigation (fig. 1).
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Fig. 1.  Associa-
tions between bio-
logical characteris-
tics of sex.
Genetic Sex
The genetic sex of an individual is considered to be the
first step in sex differentiation. Genetic sex is determined
at fertilization, when fusion of an egg and a sperm occurs.
An egg has a chromosome complement of 23,X and a
246 Horm Res 1998;50:245–251 Migeon/Wisniewski
sperm has a complement of either 23,X or 23,Y [2]. The
diploid cell which results from this fusion has either a
46,XX (genetic female) or a 46,XY (genetic male) karyo-
type [3]. Once fusion of parental gametes occurs genetic
sex is established for an individual.
Undifferentiated Structures 
During the first 6 weeks of embryonic development the
gonadal ridge, germ cells, internal ducts, and external gen-
italia are bipotential in both 46,XX and 46,XY embryos.
Under circumstances of sex differentiation: (1) the bipo-
tential gonadal ridges differentiate into either ovaries or
testes; (2) germ cells develop into either oocytes or sper-
matocytes; (3) one of the two sets of internal ducts develop
while the other regresses, and (4) bipotential external gen-
italia either masculinize or remain feminine. In instances
of normal sex differentiation, the undifferentiated struc-
tures are complementary to each other regarding classifi-
cation as male or female. In contrast, individuals with
conditions of intersex show varying degrees of discor-
dance between the sex of their gonads, internal ducts and
external genitalia.
Gonadal Ridges
A bipotential gonadal ridge is located medially on the
urogenital ridge which can be detected by 5 weeks of ges-
tation [4–6]. The gonadal ridge is considered to be a bipo-
tential gonad once germ cells migrate to this structure.
Germ cells are formed in the yolk sac and migrate at
approximately 5 weeks of embryonic development. They
contain a 46,XX or 46,XY complement [5] and undergo
mitotic divisions during the process of differentiation,
with these divisions occurring in both the fetal testis and
ovary [4, 7].
Undifferentiated Sex Ducts: The Wolffian Duct
System and the Müllerian Duct System
The 46,XX and 46,XY embryos each possess a set of
wolffian ducts as well as a set of müllerian ducts early in
development. The wolffian ducts are detected during the
4th gestational week [6, 8] and the müllerian ducts appear
later, during the 6th gestational week [4].
The wolffian duct system results in the formation of
the epididymis, vas deferens, and seminal vesicles if cer-
tain physiological conditions are met. In contrast, the
müllerian duct system will develop under a different set of
physiological conditions into the fallopian tubes, uterus,
and posterior portion of the vagina.
External Genitalia
The cloacal folds, situated around the cloacal mem-
brane, are detectable at 5 weeks of embryonic develop-
ment. Tissue destined to form the external genitalia is
located at the cranial region of the cloacal folds and sepa-
rates from the posterior region which will become the
anus. This tissue is bipotential, and thus identical in
46,XX and 46,XY embryos until 9 weeks of embryonic
development [6].
Gonadal Sex
Testis Determination 
The bipotential gonad and associated germ cells devel-
op into a testis containing type-A spermatogonia around 6
weeks of embryonic development if specific influences
from SRY, SF-1, and SOX-9 are evident (these genetic
components of testis determination are discussed in the
following section). The first of three steps observed in tes-
tis determination is the appearance of Sertoli cells which
organize themselves into seminiferous tubules and sur-
round the germ cells. Sertoli cells produce müllerian-
inhibiting substance (MIS) [9] which is necessary to inhib-
it development of the müllerian duct system (fig. 2).
The next step in testis determination from a bipoten-
tial gonad is the appearance of Leydig cells [5, 10]. Once
Leydig cells are present and stimulated by chorionic
gonadotropins early or by fetal pituitary gonadotropins
later, the fetal testis is capable of producing testosterone
[11].
The third step in testis determination is differentiation
and development of male germ cells. In the testis, germ
cells undergo mitotic arrest and subsequent formation of
spermatogonia. Two distinct mechanisms exist to explain
mitotic arrest of male germ cells: (1) physical contact
between germ cells and Sertoli cells [12], and (2) mitotic-
inhibiting substance from the seminiferous tubules [13,
14].
Genetic Control of Testis Determination
The Wilms’ tumor gene, WT1, is an important tran-
scription factor for the development of a bipotential go-
nad upon which testicular or ovarian differentiation oc-
curs [15]. So-called knock-out studies with a nuclear
receptor, steroidogenic factor-1 (SF-1) have shown that
this factor is necessary for the formation of the bipotential
gonad. Indeed, the simultaneous increase in SF-1 tran-
scription and of the DAX-1 transcript gene at the Xp21–
p22 locus suggest that both SF-1 and DAX-1 are needed
Genes and Gender Horm Res 1998;50:245–251 247
Fig. 2.  Steps necessary for testis develop-
ment.
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for the early growth of the gonads. Following develop-
ment of a bipotential gonad, several genes are required for
the complete process of testis determination. The sex-
determining region of the Y chromosome (SRY) is the
locus for the testis-determining factor (TDF), and it is
located in a 35-kb segment on the short arm of the Y chro-
mosome [16]. If a developing embryo possesses a func-
tional SRY gene, the bipotential gonad subsequently de-
velops into a testis. The absence of SRY results in gonadal
streaks in individuals with 46,XY complete gonadal dys-
genesis [17]. SF-1 appears to be involved not only in the
processes of testis determination but also in müllerian
duct regression [18] as it binds to a regulatory element
associated with MIS genes [19]. SF-1 and DAX-1 expres-
sion are detectable prior to SRY expression. It is possible
that the role of SRY is to potentiate the transcription of
SF-1, which in turn stimulates the expression of male-
differentiating genes while it suppresses the expression of
DAX-1, a stimulant of female-differentiating genes. In
addition to SRY and SF-1, SOX-9 also appears important
for testis determination and may function by interacting
with SRY [20]. Later in testicular development, SF-1 reg-
ulates cytochrome P450 steroidogenic enzymes of the
Leydig cells.
Testicular Determination in the Absence of TDF: The
Importance of Autosomal or X Chromosome Genes
Testicular determination is observed in both 46,XX
males and 46,XX true hermaphrodites. While SRY can
on occasion be translocated from the Y to an X chromo-
some in these individuals, the majority of 46,XX males
and hermaphrodites studied thus far do not possess a
translocated SRY gene [21, 22]. These findings confirm
that autosomal or X chromosome genes also play an
important role in testis determination.
In addition, male-to-female sex reversal has been ob-
served in 46,XY people in relation to duplication of a
gene at Xp21–p22 [23]. The presence of two active copies
of Xp21 is termed, dosage-sensitive sex reversal (DSS),
and DSS is located on a 160-kb region of X21 [24].
Recently, the DSS gene was confirmed to be DAX-1 [25].
As mentioned above DAX-1 appears to promote the early
formation of bipotential gonads. Since a double dose of
DAX-1 can override testis development in the presence of
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Fig. 3.  Biochemical pathways necessary
for steroid hormone production.
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SRY [15], it is hypothesized that under normal condi-
tions, SRY suppresses the feminizing effects of a single
dose of DAX-1.
Ovarian Determination
Formation of oocytes from germ cells is the first step in
ovarian determination [6]. Folliculogenesis is the second
important step in ovarian determination from the original
bipotential gonad. The third step is the development of
endocrine cells. In the human fetal ovary, cytochrome
P450 aromatase activity is present preceding ovarian dif-
ferentiation [26], but it is unclear how or where fetal ovar-
ian tissue produces sex steroid hormones.
Genetic Control of Ovarian Determination
Ovarian determination may be a default consequence
of not possessing the SRY gene. It should be noted how-
ever that evidence indicates ovarian determination may
depend on the influence of specific genes, similar to the
situation observed in testis determination [14]. Experi-
ments with Ftz-F1 knock-out mice (Ftz-F1 is the mouse
homologue that encodes for the SF-1 receptor) indicate
that these animals failed to develop gonads in either males
or females [27]. Therefore, in both sexes, SF-1 in connec-
tion with DAX-1 promotes the development of the bipo-
tential gonad. Later, the absence of SRY in the female
fetus results in decreased expression of SF-1. It is interest-
ing that an SF-1 recognition site has been localized in the
DAX-1-promoter region, indicating the potential for SF-1
to regulate DAX-1 expression [28].
Hormonal Sex
Müllerian Inhibiting Substance
MIS is important for regression of the müllerian duct
system in males and for influencing testicular formation.
MIS is also detected in females, but only after the mülleri-
an ducts are committed to development. The presence of
MIS in females and in testes suggests additional functions
of MIS in fetal development [20, 29, 30].
Testosterone
Testosterone synthesis by fetal Leydig cells starts at 8
weeks of gestation and is maximally produced around
week 13 of gestation [31]. Testosterone is crucial for devel-
opment of both the wolffian duct system and the masculin-
ization of the external genitalia. The biochemical precursor
of totestosterone is cholesterol. The four required enzymes
constituting the biochemical pathway from cholesterol to
testosterone are cholesterol side-chain cleavage, 3ß-hy-
droxysteroid dehydrogenase, 17·-hydroxylase and 17-ke-
tosteroid reductase. Cells of the external genitalia contain a
5·-steroid reductase which potentiates masculinization by
transforming testosterone to dihydrotestosterone, the most
biologically active androgen (fig. 3).
Estrogens
The conversion of C19 androgens to C18 estrogens is a
result of the action of a specific cytochrome P450, aroma-
tase. Aromatase is detectable in fetal tissue [32] indicating
that aromatization of androgens to estrogens is biochemi-
cally feasible during fetal development.
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Control of Steroid Secretion
Sex steroid hormones must bind to appropriate nuclear
receptors to be physiologically active. The resulting hor-
mone-receptor complex recognizes a specific response ele-
ment of the promoter of steroid-responsive genes and
interacts with RNA polymerase II to form a large transcrip-
tional activation complex. Expression of specific messen-
ger RNAs results from this transcriptional activation com-
plex, which then leads to translation and protein synthesis.
If any one of the steps involved in androgen transcription/
translation is defective, the result is a lack of masculiniza-
tion of internal sex ducts and external genitalia [33].
Phenotypic Sex
Phenotypic sex includes internal sex ducts and external
genitalia. Of the internal duct systems, wolffian duct
development depends upon the presence of testosterone,
and müllerian duct development depends upon the ab-
sence of MIS. The fetal testis produces testosterone in the
Leydig cells and MIS in the Sertoli cells. The fetal ovary
does not produce either testosterone or MIS at the time of
internal duct differentiation [29]. As a result, a fetus with
testes will have concomitant development of the wolffian
system and regression of the müllerian system. A fetus
with ovaries will exhibit development of the müllerian
duct system and regression of the wolffian duct system.
External Genitalia in Males
Timing is critical for masculinization of external geni-
talia. Masculinization typically begins at 7 weeks of gesta-
tion. If androgens are not present to masculinize external
genitalia until week 12 or later, full masculinization can-
not take place.
While testosterone is the sex steroid hormone which
promotes the growth of wolffian ducts, dihydrotestoster-
one is necessary to masculinize external genitalia [11].
Masculinization of external genitalia includes increasing
anogenital distance, fusion of urethral folds, and growth
and medial fusion of scrotal swellings. The penis forms
from the genital tubercle, and continues to grow through-
out gestation.
External Genitalia in Females
In the absence of testosterone, the labia majora and
labia minora form from the genital swelling and urethral
folds, respectively. The clitoris forms from the genital
tubercle. The opening of the urethra and vagina are
observed below the clitoris.
Other Phenotypic Sex Differences
Although the appearance of the external genitalia is the
basis for the diagnosis of sex at birth, there are many other
differences related to sex. There are more male than
female newborns and males are heavier than females. On
the other hand, male infantile mortality is generally great-
er than female infantile mortality. Puberty occurs earlier
in girls than in boys. Bone structure, particularly in the
pelvis, is quite different in the two sexes. Men are taller
and heavier than women, and longevity is greater in
females than in males. It is likely that some of these differ-
ences are related to the type of sex hormones secreted,
whereas other differences are not clearly understood.
As gender is the summation of various somatic differ-
ences which have been recognized, integrated and inter-
preted in the central nervous system, it is not surprising
that investigators have searched for anatomical variations
of brain structure according to sex and gender. Indeed,
morphological sex differences have been observed in the
human hypothalamus, complemented by gender differ-
ences in the suprachiasmatic nucleus [34].
Gender
Behaviors differ between males and females. The
terms gender identity, gender role, and sexual orientation
provide the focus for the present consideration of gender
[35].
Gender identity refers to the sex a person identifies
with personally (i.e., I think of myself as male or female).
Gender role refers to the sex society assigns to a person
(i.e., others regard me as male or female) [36]. Sexual
orientation refers to erotic attraction toward members of
the same sex (homosexual), the opposite sex (heterosexu-
al), or both (bisexual).
Gender identity and gender role do not correspond
with sex of rearing for some people. For example, a man
with discordant gender identity views himself as a female
while a man who takes on the public persona of a woman
is discordant for gender role. Conditions of intersexuality
provide a unique opportunity to examine gender in indi-
viduals who experience anomalous sex differentiation.
Congenital Adrenal Hyperplasia due to
21-Hydroxylase Deficiency
Congenital adrenal hyperplasia (CAH) due to 21-
hydroxylase deficiency is an autosomal recessive disor-
der. Clinical manifestations of CAH include decreases in
cortisol secretion and subsequent increases in ACTH
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secretion. As a result of increased ACTH output, the pro-
duction of adrenal androgens increase, leading to mascu-
linization of external genitalia in female fetuses.
CAH girls and women provide an opportunity to
investigate gender in individuals who are concordant for
genetic sex (46,XX) and internal duct sex (müllerian
development and wolffian regression), but who are discor-
dant for hormonal sex (prenatal exposure to excessive
androgens) and external genital sex (ambiguous or fully
masculinized).
A number of studies report masculinized or defemi-
nized play behavior (an index of gender role) in CAH
girls. In contrast, CAH females do not typically report a
conflict with their female gender identity [37–39]. Con-
cerning sexual orientation, some studies indicate in-
creased bisexual/homosexual fantasy and behavior in
CAH women while others do not.
A great deal of variability exists in the expression of
masculinized/defeminized behaviors among CAH pa-
tients studied thus far. One explanation for this variabili-
ty is that varying degrees of androgen exposure and geni-
tal masculinization in these girls differentially influences
their behavior. Another possibility, at least in terms of
sexual behavior, is the practical issue of the adequacy of
vaginal constructive surgery for heterosexual intercourse.
In CAH studies comparing the salt-wasting (SW) form of
CAH with the simple-virilizing (SV) form, SW women
were less likely to be married or had fewer children than
SV women [37]. The SW/SV distinction is important
because SW women were less likely to report a satisfactory
introitus, and correspondingly were less likely to report
heterosexual activity. At present, the clearest predictor of
heterosexual behavior in CAH populations is an introitus
considered adequate for heterosexual sex.
Androgen-Insensitivity Syndrome
Normal male sexual differentiation requires that every
one of the differentiating steps occurs in the appropriate
fashion with appropriate timing. Deviation at any step
can result in female or ambiguous external genitalia. One
possible deviation involves the partial or complete ab-
sence of androgen receptor activity. A complete absence
results in complete androgen insensitivity. These subjects
present female-appearing external genitalia, lack of sexual
hair and breast development while simultaneously pro-
ducing male-typical concentrations of testosterone. Yet,
these persons report a feminine gender role and gender
identity [39, 40]. Perhaps the fact that their original
female sex of rearing influenced their gender develop-
ment.
When the mutation of the androgen receptor gene
results in partial receptor activity, the subjects present
various degrees of ambiguity of the external genitalia. At
puberty there is poor sexual hair growth and breast devel-
opment. Sex of rearing may be male or female but little is
known about gender in this population.
Ablatio Penis
Recently, investigations of gender were reported for 2
individuals who experienced normal male sex differentia-
tion prenatally, but who suffered from ablatio penis post-
natally. In each case, both individuals were assigned and
raised as girls. In one instance, the individual during ado-
lescence chose to have a sex re-reassignment to that of a
male. Additionally, this individual identifies himself as a
heterosexual male who displayed masculine play behavior
during his childhood while living as a girl [41]. In contrast,
a second case was reported in which the individual identi-
fies with being a bisexual female [42].
Conclusions
Sex is multifaceted. Associations clearly exist among
many of the steps comprising sex differentiation of genita-
lia and reproductive tracts. What is not well understood at
this point is the influence of these steps on behavior in
humans. More investigations of gender are needed among
intersex populations, as well as among the general popula-
tion, to determine whether the physiological processes of
sex differentiation affect gender role, gender identity and
sexual orientation.
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